Marker Therapeutics, Inc. — Director's Dealing 2020

Mar 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Marker Therapeutics, Inc. (MRKR)
CIK: 0001094038
Period of Report: 2020-03-10

Reporting Person: Szymanska Anna (Vice President, Quality)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$4.84	2029-09-30	Common Stock (60000)		Direct

Footnotes

F1: 1. Twenty-five percent (25%) of the shares underlying the Option shall vest on October 10, 2020, with the balance of the shares vesting in thirty-six (36) equal monthly installments thereafter.